Search

Nevis Fregien Phones & Addresses

  • 9285 90Th St, Miami, FL 33176 (305) 595-6445
  • Coral Gables, FL
  • Arlington, VA
  • Lodi, CA
  • Morrow, GA
  • San Joaquin, CA

Publications

Us Patents

Transmembrane Glycoprotein Asgp-2: Nucleotide Sequences And Recombinant Production Of Proteins

View page
US Patent:
56248164, Apr 29, 1997
Filed:
Jan 3, 1994
Appl. No.:
8/179481
Inventors:
Kermit L. Carraway - Miami FL
Coralie A. Carothers Carraway - Miami FL
Nevis L. Fregien - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
C12N 1512
US Classification:
435 691
Abstract:
The present invention relates, in general, to a glycoprotein that is a member of the epidermal growth factor superfamily ASGP-2. In particular, the present invention relates to a DNA segment encoding the glycoprotein; to a recombinant DNA molecule containing the DNA segment; to cells containing the recombinant DNA molecule; to a method of producing the glycoprotein; and to methods of disease diagnosis and therapy that involve the use of the glycoprotein or DNA segment encoding same.

N-Acetylglucosaminyltransferase V Proteins And Coding Sequences

View page
US Patent:
60157011, Jan 18, 2000
Filed:
Jul 19, 1994
Appl. No.:
8/276968
Inventors:
James Michael Pierce - Athens GA
Mohamed G. Shoreibah - Comer GA
Beverly Adler - Newbury Park CA
Nevis Lee Fregien - Miami FL
Assignee:
University of Georgia Research Foundation, Inc. - Athens GA
Amgen, Inc. - Thousand Oaks CA
International Classification:
C12N 1554
C12N 1574
C12N 1585
US Classification:
435193
Abstract:
The present invention provides substantially purified UDP-N-acetylglucosamine:. alpha. -6-D-mannoside. beta. -1,6-N-acetylglucosaminyl transferase (GlcNAc T-V; EC 2. 4. 1. 155) proteins and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by GlcNAc T-V coding sequences from rat, hamster, mouse and human.

N-Acetylglucosaminyltransferase V Gene

View page
US Patent:
56020031, Feb 11, 1997
Filed:
Feb 10, 1993
Appl. No.:
8/016863
Inventors:
J. Michael Pierce - Athens GA
Mohamed G. Shoreibah - Comer GA
Beverly S. Adler - Newbury Park CA
Nevis L. Fregien - Miami FL
Assignee:
University of Georgia Research Foundation - Athens GA
International Classification:
C07H 2104
C12N 510
US Classification:
435 691
Abstract:
The present invention provides a substantially purified UDP-N-acetylglucosamine:. alpha. -6-D-mannoside. beta. -1,6-N-acetylglucosaminyltransferase (GlcNAc T-V; EC 2. 4. 1. 155) and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by a GlcNAc T-V coding sequence from rat.
Nevis L Fregien from Miami, FL, age ~73 Get Report